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Abstract
Background: Thickening of reticular basement membrane, increased airway smooth muscle mass and eosinophilic
inflammation are found in adult fatal asthma. At the present study the histopathology of fatal paediatric and
adolescent asthma is evaluated.
Methods: Post-mortem lung autopsies from 12 fatal asthma cases and 8 non-asthmatic control subjects were
examined. Thickness of reticular basement membrane (RBM) and percentage of airway smooth muscle (ASM%)
mass area were measured and inflammatory cells were counted. Patient records were reviewed for clinical history.
Results: The age range of the cases was from 0.9 to 19.5 years, eight were males and five had received inhaled
corticosteroids. Thickened RBM was detected in majority of the cases without any correlation to treatment delay,
age at onset of symptoms or diagnosis. In the large airways ASM was clearly increased in one third of the cases
whereas the median ASM% did not differ from that in healthy controls (14.0% vs. 14.0%). In small airways no increase of
ASM was found, instead mucous plugs were seen in fatal asthma. The number of eosinophils, plasmacytoid dendritic
cells, macrophages, and B-cells were significantly increased in fatal asthma cases compared with controls and the two
latter correlated with the length of the fatal exacerbation.
Conclusions: The findings highlight the strong presence of eosinophils and mucous plugs even in small airways in children
and adolescents with fatal asthma. Thickened RBM was obvious in majority of the patients. Contrary to our hypothesis,
increased ASM% was detected in only one third of the patients.
Keywords: Airway smooth muscle, Eosinophils, Fatal pediatric and adolescent asthma, Histopathology, Reticular
basement membrane
Background
It is thought that inflammation and remodelling occur
together in asthma [1]. Remodelling is characterized by
epithelial injury, thickening of reticular basement mem-
brane (RBM), airway smooth muscle (ASM), goblet cell
hypertrophy and hyperplasia, and angiogenesis, whereas
the inflammation is merely eosinophilic [2].
The thickness of RBM increases naturally during
childhood. RBM thickness of cartilaginous bronchi in-
creases rapidly until 6 years of age thereafter slowly until
17 years of age [3]. Thickened RBM was detected in
school children with moderate and severe asthma [4–9],
in pre-schoolers with severe wheeze and in mild-to-
moderate asthma [4–9] but not in children below two
years with recurrent lower airway symptoms regardless
of lung function [10].
Increased thickness of ASM is seen in severe adult
asthmatics especially in large airways [11, 12] and both
ASM hyperplasia and hypertrophy contribute [13, 14].
In children ASM hypertrophy and hyperplasia in large
airways were described in six children (6–17 years) with
severe corticosteroid-dependent asthma [5]. Subse-
quently ASM hyperplasia and hypertrophy in large air-
ways were present even in moderate-to-severe asthma in
children 7–16 years of age [15].
Chronic airway inflammation in asthma is thought to
compose of eosinophils, mast cells, and T-lymphocytes.
Airway eosinophilia has been contradictory in childhood
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asthma especially in early disease. However, varying de-
gree of bronchial eosinophilia without increased neutro-
phils or mast cells was detected in children with severe
treatment-resistant asthma [16].
We re-examined autopsied lung sections for remodel-
ling and airway inflammation from Finnish children and
adolescents with fatal asthma and compared these to
those obtained from healthy age-related controls with
accidental death. We hypothesized that RBM and ASM
mass are increased in fatal asthma.
Methods
Study subjects
Fatal asthma cases were derived from a death certificate
study on fatal asthma in children and adolescents 1976–
1998 [17]. Lung tissue autopsies were collected from
laboratories in Finland. Data on clinical history and treat-
ment was obtained from patient records. Lung autopsies
from 8 children with accidental death between 2006–
2010, received from medico-legal autopsies, served as con-
trols. Patient records were reviewed for asthma and atopy.
A subject was considered to have atopy if atopic eczema,
allergic rhino-conjunctivitis or food allergy were reported.
Approval for study was obtained from Ministry of Social
Affairs and Health, National Supervisory Authority for
Welfare and Health, and Ethics Committee for Hospital
for Children and Adolescents.
Tissue preparation
Autopsies were performed using standard medico-legal
autopsy protocols. Lung specimen was fixed in formalin
before paraffin embedding, microscopic slide prepar-
ation and staining. Bronchi, airways with cartilage and
hereafter called as large airways, as well as bronchioles,
muscularized columnar lined airways without cartilage,
less than 0.4 mm diameter and hereafter called as small
airways, were analyzed. The outer luminal diameter of
bronchi was measured from outer layer of bronchial wall
outside cartilage whereas the inner luminal diameter of
bronchi was measured from inner side of epithelial layer.
The thickness of bronchial wall was difference of these
parameters. Bronchiolar diameter was measured from
outer wall of muscular layer.
Due to the retrospective nature of this study, site of
the lung samples were no specified and measured indi-
ces may have varied in different part of lungs.
RBM and ASM measurements
Thickness of RBM was measured from Herovici stained
sections in two fashions. 1) Perpendicular method: repre-
sentative perpendicular areas were selected for each air-
way and RBM thickness was manually measured (10–15
individual measurements). 2) Grid-overlay method: whole
airway circumference was photographed. Measure points
were randomly selected using grid-overlay method. Indi-
vidual measurements varied in number from 50–200.
To measure the amount of ASM samples stained for
smooth muscle actin were photographed. The area of
airway was determined manually following outlines of
smooth muscle layer, Fig. 1. When smooth muscle layer
was discontinuous, a straight line was drawn between
the nearest visible smooth muscle bundles. If such line
intersected the epithelium, the outline was determined
by the outline of epithelium. The picture was divided
into non-muscle and muscle areas and converted to
black and white. To determine if a pixel belonged to the
smooth muscle area it was passed through a color
threshold filter. Brown-red-colored areas passed as
smooth muscle. In some samples epithelium or other
cells inside the muscle layer had a red-brown tint and
the tinted non-muscle areas were masked with white
color before measurement. The amount of smooth
muscle is expressed as percentage of cross sectional area
of the airway (ASM%). Increased RBM and ASM% were
defined as more than one standard deviation above the
mean value for control subjects.
Inflammatory cells and mucus
Inflammatory cells were identified in mucosa and submucosa
by immunostaining using antibodies: T-lymphocytes (CD3,
2GVG Ventana, Roche), B-lymphocytes (CD20, L26 Ventana,
Roche), plasma cells (CD138, B-A38, Ventana, Roche),
mast cells (CD117, polyclonal, Dako), and macro-
phages (CD163, 10D6, Novocastra). Plasmacytoid den-
dritic cells (PDC) were identified as CD-123 positive
cells (CD123, a mixture of clone 7G3, IgG2a and
clone 9 F5, IgG1; BD Pharmingen, CA) with typical
plasmacytoid morphology as described [18]. Identifica-
tion of conventional dendritic cells with anti-CD11c
Fig. 1 Smooth muscle was quantified from smooth muscle actin
stained sections (brown), and expressed as percentage of muscle of
total bronchiolar cross sectional area (small airway ASM%), bar 50 um
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gave variable staining quality and was rejected. Eosin-
ophils were counted from hematoxylin-eosin slides.
Neutrophilic leukocytes and eosinophils were stained
with CD15 (MMA, Roche) and identified based on
morphology. Results were expressed as number of
cells/subepithelial area (1/mm2). Mucous plug was
identified by Alcian Blue-Periodic Acid-Schiff stain
and scored semi-quantitatively: 0 = none; 1 = some; 2
= prominent; 3 = obstructive.
Statistical analysis
Mann-Whitney’s test was used to compare results be-
tween the groups and Wilcoxon’s test within the
groups for non-normal data. Comparison of means
with normally distributed variables was done with
t-test. The associations between histological and clin-
ical findings were evaluated with Spearman’s correla-
tions and Chi2-tests. Two-sided p-values <0.05 were
considered statistically significant.
Results
Median age at asthma death was 3.1 years (range 0.9 to
19.5) for 12 cases compared with 5.5 years (range 0.1 to
16.4) for eight controls, Table 1. Of the cases with reli-
able information, 4/6 cases had parental asthma and 9/9
cases had atopy whereas all controls were non-atopic.
Symptoms of acute respiratory airway infection were re-
ported in 9/12 cases. Length of fatal asthma exacerba-
tion, i.e. time from beginning of exacerbation till death,
was available in 11/12 cases and the median length was
2.0 days. Inhaled corticosteroids were used regularly by
5/12. Median delay of any anti-inflammatory asthma
medication from beginning of symptoms was 0.8 years.
The number of identified large and small airways was
1–4 and 2–15 per sample. Median diameters of these air-
ways are presented in Table 2. Individual remodelling and
immunohistological findings are presented in Table 3.
Remodelling
Thickness of RBM in large airways was significantly in-
creased in fatal asthma cases compared with controls, by
both perpendicular and grid overlay methods (p = 0.001
and p = 0.002, Mann Whitney), Table 2, Figs. 2a&b.
Thickness of RBM increased significantly with age in
both groups, Fig. 3a. Thickness of RBM in fatal asthma
did not correlate with any other clinical parameter pre-
sented in Table 1.
ASM was clearly increased in large airways in 4/
12 fatal asthma cases, Figs. 2c&d, but median
ASM% did not differ from that in controls (15.1%
vs. 15.0%) Fig. 3b. The ASM% in large airways in-
creased with age (r = 0.802; p = 0.003, Spearman)
Fig. 3c and correlated with RBM in fatal asthma
(RBM by grid-overlay method r = 0.718; p = 0.011
and by perpendicular method r = 0.601; p = 0.039,
Spearman). ASM% in large airways correlated significantly
with lifetime duration of asthma symptoms (r = 0.715;
p = 0.017, Spearman).
ASM% in small airways was found equally in both
groups (median 14.0% vs. 14.0%), Figs. 4a&b without any
increase with age Figs. 3d. ASM% in small airways corre-
lated negatively with age at the onset of asthma symp-
toms (r = -0.794; p = 0.004, Spearman).
Table 1 Demographics of the fatal asthma cases
Sex Age at
death (y)














F 1,9 1,1 0,8 NA 0,8 0,0 – – NA
M 18,9 0,5 18,4 3 6,5 11,9 – T, C 1
M 0,9 NA NA NA NA NA NA NA NA
M 1,9 1,1 0,8 1,5 0,4* 0,4* – – 1
F 2,6 0,7 1,9 0,8 0,1 1,8 1 T, C 1
M 18,1 1,0 17,1 1,3 12,0 5,1 – T 1
M 19,5 1,0 18,5 3 3,0 15,5 1 T, C 1
F 6,0 2,2 3,8 NA 3,8 0,0 – – 1
M 2,4 0,7 1,7 0,9 0,2 1,5 1 T 1
F 1,8 1,5 0,3 1,7 0,2 0,1 – T 1
M 18,7 15,0 3,7 17,8 2,8 0,9 1 LABA 1
M 3,6 0,8 2,8 0,9 0,1 2,7 1 C 1
Median 3,1 1,0 2,8 1,5 0,8 1,7
Abbreviations: ICS inhaled corticosteroids, T theophyllin, C cromoclygate, LABA long-acting beta-agonist, NA non-available information
*Theophyllin was given at exacerbations during the last five months
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Inflammation
Macrophages (Figs. 5a&b), B-cells, eosinophils and PDCs in
large airways were significantly increased in fatal asthma
compared to controls, Table 2. In some cases eosinophils
were found in large numbers both in airway lumen and
mucosa. Eosinophils were easy to identify in hematoxylin-
eosin stained sections. Due to degeneration and crushing
artefact, neutrophils were difficult to identify and therefore
CD15+ cells (including both eosinophils and neutrophils)
were counted. In CD15 staining eosinophils stained only
lightly in contrast to strongly stainable neutrophils that
were counted, Fig. 5c. An effort was made to stain plasma
cells with syndecan (CD138) but due to autolysis of autopsy
samples even epithelial cells had impaired antigenicity.
Thickness of RBM correlated negatively with numbers
of B-cells and mast cells (r =−0,692; p = 0.023, and
r =−0.674; p = 0.016, Spearman) whereas a significant
correlation between numbers of macrophages and B-cells
(r = 0.790; p = 0.002, Spearman) as well between numbers
of PDCs and T-cells (r = 0.692; p = 0.013, Spearman) were
seen in fatal asthma. In addition, a significant correlation
was detected between numbers of CD15+ cells and
macrophages (r = 0.648; p = 0.023, Spearman) and between
CD15+ cells and T-cells (r = 0.613; p = 0.034, Spearman)
in fatal asthma. Numbers of macrophages and B-cells
correlated with the length of fatal asthma exacerbation
(r = 0.664; p = 0.026 and r = 0.7; p = 0.016, Spearman) while
number of T-cells correlated with total lifetime duration of
asthma symptoms (p = 0.636; r = 0.035, Spearman).
Mucous plugs were found in large and small airways
significantly more prominently in fatal asthma than in
controls, especially in large airways (p = 0.002, Wilcoxon
test), Table 2, Figs. 4c&d.
Discussion
In this postmortem study, airways of 12 fatal childhood and
adolescent asthma cases and 8 controls were evaluated. As
anticipated, thickened RBM was found in fatal asthma but
contrary to our hypothesis, ASM% was increased only 1/3
of fatal asthma cases, exclusively in large airways. Large air-
way ASM% increased with age and correlated with RBM
and duration of asthma. Our findings also highlight the
strong presence of eosinophils in fatal asthma. Moreover, as
signs of fulminant inflammation, PDCs, macrophages, B-
cells, and amount of mucus were increased in fatal asthma.
Remodelling
RBM thickness increases during childhood through ado-
lescence in healthy children [3]. The present study con-
firms these findings adding that the increase is 0.1 um/
year. Thickened RBM, the sign of remodeling [4–7], was
seen in most of the cases with fatal asthma in this study.
ASM hyperplasia and hypertrophy are thought to
discriminate severe asthma from milder disease, and are
Table 2 Remodelling and immunohistological findings
Fatal asthma cases Healthy controls p*
RBM, um [median, (IQR)]a 5,7 (2,8) 2,3 (1,3) 0.001
RBM, um [median, (IQR)]b 5,3 (1,8) 3,4 (0,8) 0.002
ASM large AW, %, [median, (IQR)] 15,1 (15,6) 15 (3,5) 0.933
ASM small AW, % [median, (IQR)] 14,0 (7) 14,0 (8) 0.553
T cells [median, (IQR)] 197 (159) 213/126) 0.866
B cells [median, (IQR)] 43 (95) 19,3 (18) 0.028
Macrophages [median, (IQR)] 216 (110) 93 (22) 0.001
Mast cells [median, (IQR)] 73 (23) 75 (220) 0.8
CD15 + cells [median, (IQR)] 53 (187) 65 (130) 0.671
Eosinophils [median, (IQR)] 120 (220) 0 (4) <0.001
Plasmacytoid dendritic cells, [median, (IQR)] 20 (30) 4 (10) 0.012
Mucus bronchi [median, (IQR)] 2 (1) 1 (1) <0.001
Mucus bronchioles [median, (IQR)] 1 (0) 0 (0) <0.001
Outer luminal diameter, large AW, mm [median, (IQR)] 2,0 (1,1) 1,5 (0,8) 0.069
Inner luminal diameter, large AW, mm [median, (IQR)] 1,0 (0,4) 0,9 (0,4) 0.353
Wall thickness, large AW, mm [median, (IQR)] 0,9 (0,9) 0,7 (0,4) 0.103
Luminal diameter, small AW, mm [median, (IQR)] 0,3 (0,1) 0,2 (0,1) 0.472
Abbrevations: RBM reticular basement membrane, IQR interquartile range, ASM airway smooth muscle, AW airways
*Mann Whitney’s test for continuous variables
All the bolded p-values are of significance (they are < 0.05)
aPerpendicular method
bGrid overlay method
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associated with bronchodilator and increased airway re-
sponsiveness [15, 19]. We expected thickened ASM% in
both large and small airways in fatal asthma, especially
among the oldest patients with longest duration of asthma.
ASM% in large airways increased with age only in fatal
asthma but there was no difference in median ASM% be-
tween asthmatics and controls. Time from death to autopsy
and specimen preservation in formalin was more extensive
in medico-legal cases used as controls compared to fatal
asthma cases. This may have caused autolysis and thereof
loosened tissues leading to thicker ASM% in controls.
Since peripheral obstruction is the clinical and functional
finding in asthma exacerbation in young children [10] at
least some ASM increase in small airways was expected
but no increase was detected. The only significant finding
in the small airways in fatal asthma cases compared to
controls was increased amount of mucus in all but one.
Mucus in small airways with luminal diameter < 0.3 mm
may contribute to the fatal outcome. To our knowledge
there are no reports on ASM in small airways in children
with asthma. Recently, small airway ASM was found
increased in 41% fatal adult asthmatics whereas pathology
limited only to small airways was uncommon [20].
Studies of ASM in severe and fatal childhood asthma
are rare. In an observational study, two children with
fatal asthma were reported to have thickened RBM and
increased bronchial ASM [21]. Similar findings were re-
ported in 4/5 children with non-fatal, difficult-to-control
asthma [5]. Bronchial ASM was significantly increased
in 24 children (7–16 years) with moderate-to-severe
asthma compared to 11 controls (12–49% versus 2–5%)
[15]. Both median number size of ASM cells were in-
creased in asthmatics. Our results are partly in accord-
ance with a study of severe therapy-resistant asthma
(10–14 years) in which increased bronchial eosinophilia,
RBM and ASM mass were found [16]. Increased ASM in
severe preschool wheeze was found to discriminate chil-
dren from those not going to have asthma at school age
[22]. The fact that our samples present fairly small air-
ways (median outer luminal diameter in large airways
2 mm and luminal diameter in small airways < 0.3 mm)
can also have impact to the low median ASM%.
Table 3 Individual remodelling and immunohistological findings









2,8 4,4 13 11 121 118 431 129 27 23 0 2,5 1
5,6 5,6 29 17 309 30 345 353 65 140 4 2 1
2,3 3,4 7 9 1097 560 875 154 1240 659 100 3 1
4,0 3,9 9 17 297 64 342 149 77 80 4 2 1
6,9 6,3 15 20 191 49 455 92 240 140 20 3 2
5,8 6,2 20 14 393 87 300 113 653 73 80 2 1
6,4 5,7 28 14 521 19 239 106 360 87 20 3 0
3,4 4,6 12 8 508 225 500 149 20 813 24 2 1
6,4 4,7 14 18 421 443 1133 153 320 107 20 3 1
4,8 5 10 NA 166 51 320 151 700 140 14 3 1
6,6 6,4 17 13 150 35 161 79 1 9 20 3 2,5
6,2 5,6 35 19 427 194 520 146 467 447 40 2 1
Controls
2,3 3,8 6 6 NA 22 158 140 0 640 0 0 0
3,1 4,9 16 14 454 29 184 248 0 147 0 1 0
1,7 3,3 16 22 257 25 219 169 0 73 12 0 0
3,2 3,6 18 17 487 51 204 95 6 47 4 1 0
1,7 2,6 14 9 400 81 167 131 12 320 8 1 0
2,8 3,4 14 11 450 48 188 187 0 347 4 0 0
1,8 2,4 11 14 68 12 157 65 0 113 12 1 0
2,4 3,3 NA NA 325 NA 144 NA 0 120 4 0 0
Abbreviations: RBM reticular basement membrane, ASM airway smooth muscle, AW airways, MF macrophage, PDC plasmacytoid dendritic cell, NA
non-available information
aAll cell counts are per mm2
bPerpendicular method
cGrid overlay method
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Fig. 3 a Thickness of RBM increased significantly with age both in fatal asthma (FA) 0.079 um/year (r = 0.698; p = 0.014, Spearman) and in controls
(C) 0.085 um/year (r = 0886; p = 0.006 Spearman). RBM measured by grid-overlay method. b Distribution of ASM% in large airways in fatal asthma
(FA) and in healthy controls (C). c ASM% in large airways increased significantly with age (0.6%/year) in fatal asthma (FA) (r= 0.787; p= 0.003, Spearman)
but not in controls (C) (−0.04%/year) (r= 0.145; p= 0.762, Spearman). d ASM% in small airways did not change over time in fatal asthma (FA) (0.1%/year)
nor in controls (C) (−0.2%/year)
Fig. 2 a Bronchial thickness of reticular basement membrane (RBM) (red) is increased in a 2.6 year old fatal asthma case (mean 6.9 um) whereas
(b) the thickness of RBM is normal in a 2.5 year old control (mean 1.7 um) (hematoxylin-eosin stain; bars 50 um). c Increased ASM (brown) in a large
airway in 19.5 year old fatal asthma case (mean ASM% 28%) compared with (d) that in a 6.0 year old fatal asthma (mean ASM% 12%) (smooth muscle
actin stain; bars 250 um)
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Fig. 4 a Thickness of ASM in a small airway (brown), in a 19.5 year old fatal asthma case (mean ASM% 14%) is similar to (b) that in a 14.9 year old
control (mean ASM% 14%) (smooth muscle actin; bars 50 um). c Large airway (bronchial) lumen in a 2.4 year old fatal asthma case filled with mucous
(Alcian Blue-Periodic Acid-Schiff; bar 250 um). d Small airway (bronchiolar) lumen filled with mucous (blue) in a 18.7 year old fatal asthma case (Alcian
Blue-Periodic Acid-Schiff; bar 50 um)
Fig. 5 a Bronchial macrophages (brown) are increased in epithelium and subepithelium in a 3.6 year old fatal asthma case (CD163; bar 50 um)
whereas (b) only few bronchial macrophages are found in subepithelium in a 2.5 year old control (bar 100 um). c Bronchial mucosa of a 0.9 year
old fatal asthma case had numerous eosinophils (lightly positive cells in CD15 staining, brownish) and only a few neutrophils (strongly positive
cells in CD15 staining, dark brown) (bar 50 um)
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In the present study the increase of ASM% in large air-
ways with age was greater in fatal asthma cases com-
pared to healthy controls. To our knowledge, there is no
published report on this in children. In a study with
adults, 18–48 years of age, including patients with fatal
and non-fatal asthma and controls, these findings were
slightly different [23]. Hypertrophy of ASM cells was
found in large airways in both fatal and non-fatal asth-
matics whereas hyperplasia of ASM was present in the
large and small airways in fatal asthma only. They re-
ported only small or negligible effects of age on ASM
cell number or size in fatal asthma.
Here we show that duration of asthma correlated with
ASM% in large airways. Similarly, duration of asthma
had a small positive effect on ASM area in large airways
in adult fatal and non-fatal asthma [23]. It was suggested
that increase of ASM occur early in childhood and
ASM hyperplasia may contribute to clinical severity.
Unfortunately, we did not have the possibility to
measure volume or number of ASM cells. Instead we
measured ASM area, which is comparative to airway
smooth muscle layer thickness, ASM area, used by
James et al [23].
Inflammation
Bronchial eosinophils were not detected in symptomatic
children under 2 years of age [10], whereas they were
detected in severe wheeze between 2–4 years [24]. In the
present study, numerous eosinophils were found in all
but one of the fatal asthma cases independently of age.
Although findings from adults cannot be translated to
children, an increased number of bronchial eosinophils
has been a hallmark of severe asthma in adults [20]. In
that study, an increased thickness of ASM layer was as-
sociated with airway remodelling and eosinophilia but
not with neutrophilia [20]. Neutrophils were not in-
creased in our study population either. Mast cells are an-
other prominent cell population in severe adult asthma.
Balzar et al. described a predominance of mast cells
positive for both tryptase and chymase in the bronchial
submucosa and epithelium in adults with severe asthma
[25]. In this study, the number of mast cells in large air-
ways was similar in fatal asthma cases and controls.
We found respiratory infection most likely cause of
fatal attack. Elevated numbers of bronchial macrophages
and B-cells as well association between DCs and T-cells
could reflect the acute nature of the fatal exacerbations.
We showed also that PDCs were significantly increased
in asthmatic airways. Increased numbers of PDCs have
been found in human experimental model of allergic
rhinitis [26] and in experimental models of asthma in
mice [27]. They may play a regulatory role inducing
Treg differentiation. PDCs are also involved in defence
against various viruses producing IFN-α. However, children
with allergic asthma has reduced production of IFN-α
by cross-linkage of high affinity IgE-receptor [28].
PDCs are under homeostatic conditions mainly found
in secondary lymphoid organs and not in peripheral
tissues as lungs. Their accumulation suggests a role
in the inflammatory process.
Conclusions
To our knowledge there are no reports on airway
smooth muscle mass in small airways in children with
asthma. Undertreated asthma in children and adoles-
cents leads to eosinophilic inflammation, excess of
mucus, and remodelling of large airways, i.e. thickened
RBM and in minority increased ASM%, but to no other
changes in small airways than mucus. Duration of
asthma correlated with ASM% in large airways. These
findings should alert clinicians to careful examination
and proper treatment of children with unstable and diffi-
cult asthma.
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